Adimmune (TPE:4142) Short Interest


TPE:4142 Adimmune Corp TPE:4142
55 GF Score
Price NT$16.80
GF Value NT$25.40
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Adimmune Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TPE:4142 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Adimmune's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adimmune Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adimmune's Short Interest distribution charts can be found below:

* The bar in red indicates where Adimmune's Short Interest falls into.


TPE:4142
55GF Score
Adimmune Corp TPE:4142
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$16.80 is trading 33.9% below its estimated GF Value™ of NT$25.40. GuruFocus considers Adimmune to be Possible Value Trap.

Key valuation signals for TPE:4142:

  • Short Interest:
  • GF Value™: NT$25.40 vs. price of NT$16.80 (33.9% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adimmune Business Description

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
55GF Score

Get the complete analysis for TPE:4142

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.80
Price
NT$25.40
GF Value